all AI news
Synthetic Data from Diffusion Models Improve Drug Discovery Prediction
May 8, 2024, 4:41 a.m. | Bing Hu, Ashish Saragadam, Anita Layton, Helen Chen
cs.LG updates on arXiv.org arxiv.org
Abstract: Artificial intelligence (AI) is increasingly used in every stage of drug development. Continuing breakthroughs in AI-based methods for drug discovery require the creation, improvement, and refinement of drug discovery data. We posit a new data challenge that slows the advancement of drug discovery AI: datasets are often collected independently from each other, often with little overlap, creating data sparsity. Data sparsity makes data curation difficult for researchers looking to answer key research questions requiring values …
abstract advancement artificial artificial intelligence arxiv challenge cs.ai cs.lg data datasets development diffusion diffusion models discovery drug development drug discovery every improvement intelligence posit prediction q-bio.qm stage synthetic synthetic data type
More from arxiv.org / cs.LG updates on arXiv.org
Efficient Data-Driven MPC for Demand Response of Commercial Buildings
2 days, 14 hours ago |
arxiv.org
Testing the Segment Anything Model on radiology data
2 days, 14 hours ago |
arxiv.org
Calorimeter shower superresolution
2 days, 14 hours ago |
arxiv.org
Jobs in AI, ML, Big Data
Software Engineer for AI Training Data (School Specific)
@ G2i Inc | Remote
Software Engineer for AI Training Data (Python)
@ G2i Inc | Remote
Software Engineer for AI Training Data (Tier 2)
@ G2i Inc | Remote
Data Engineer
@ Lemon.io | Remote: Europe, LATAM, Canada, UK, Asia, Oceania
Artificial Intelligence – Bioinformatic Expert
@ University of Texas Medical Branch | Galveston, TX
Lead Developer (AI)
@ Cere Network | San Francisco, US